CONGIU, CENZO
 Distribuzione geografica
Continente #
EU - Europa 142.266
NA - Nord America 8.617
AS - Asia 3.672
SA - Sud America 547
AF - Africa 125
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 155.241
Nazione #
IT - Italia 133.042
US - Stati Uniti d'America 8.527
NL - Olanda 6.665
CN - Cina 1.400
SG - Singapore 1.377
UA - Ucraina 909
BR - Brasile 445
FI - Finlandia 402
SE - Svezia 351
DE - Germania 331
VN - Vietnam 287
GB - Regno Unito 217
FR - Francia 205
HK - Hong Kong 117
IN - India 109
KR - Corea 101
CA - Canada 57
MA - Marocco 45
BD - Bangladesh 43
RU - Federazione Russa 40
AR - Argentina 38
JP - Giappone 28
EG - Egitto 26
MX - Messico 26
IQ - Iraq 25
PK - Pakistan 24
ES - Italia 21
TR - Turchia 20
EC - Ecuador 19
ID - Indonesia 18
BE - Belgio 17
ZA - Sudafrica 17
VE - Venezuela 16
AT - Austria 13
CO - Colombia 12
IR - Iran 12
SA - Arabia Saudita 12
JO - Giordania 11
TN - Tunisia 11
UZ - Uzbekistan 10
MY - Malesia 9
TW - Taiwan 9
AZ - Azerbaigian 8
PH - Filippine 8
PT - Portogallo 8
TH - Thailandia 8
IE - Irlanda 7
IL - Israele 7
OM - Oman 7
PL - Polonia 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CL - Cile 6
CZ - Repubblica Ceca 6
EU - Europa 6
HU - Ungheria 6
KE - Kenya 6
PE - Perù 6
NP - Nepal 5
DZ - Algeria 4
LT - Lituania 4
NG - Nigeria 4
RS - Serbia 4
KZ - Kazakistan 3
RO - Romania 3
UY - Uruguay 3
CI - Costa d'Avorio 2
DK - Danimarca 2
GA - Gabon 2
LB - Libano 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MU - Mauritius 1
PA - Panama 1
PY - Paraguay 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
ZW - Zimbabwe 1
Totale 155.241
Città #
Cagliari 130.103
Amsterdam 6.650
Uta 2.489
Woodbridge 892
Fairfield 742
Ashburn 631
Singapore 592
Chandler 538
Houston 535
Jacksonville 517
Wilmington 430
Ann Arbor 416
Dallas 403
Boardman 391
San Jose 333
Seattle 301
Cambridge 281
Helsinki 252
Nyköping 247
Beijing 200
Dearborn 154
Nanjing 148
Boston 123
Hefei 120
Los Angeles 120
Lauterbourg 115
Santa Clara 98
Ho Chi Minh City 94
Hong Kong 90
Munich 90
The Dalles 89
Seoul 84
Shanghai 74
New York 69
Buffalo 67
Nanchang 61
Hanoi 55
Shenyang 53
Milan 50
Hebei 46
San Diego 44
Council Bluffs 43
Verona 40
Guangzhou 39
Jiaxing 39
Tianjin 37
São Paulo 36
Toronto 35
Redwood City 34
Changsha 33
Dong Ket 32
Casablanca 31
Mountain View 29
Redondo Beach 29
Auburn Hills 23
Norwalk 23
Olbia 23
Atlanta 22
Washington 22
Orange 21
Frankfurt am Main 19
Tokyo 19
Zhengzhou 19
Chicago 17
Jinan 17
London 17
Turku 16
Phoenix 15
Selargius 15
Belo Horizonte 14
Chennai 14
Ferrara 14
Sassari 14
Falls Church 13
Hangzhou 13
Brooklyn 12
Brussels 12
Cairo 12
Columbus 12
Da Nang 12
San Francisco 12
Dhaka 11
Ningbo 11
Nuremberg 11
Orem 11
Rome 11
Wuhan 11
Amman 10
Haiphong 10
Manchester 10
Perugia 10
Quito 10
Rio de Janeiro 10
Kunming 9
Baghdad 8
Brasília 8
Chapel Hill 8
Indiana 8
Messina 8
Monserrato 8
Totale 149.869
Nome #
Synthesis and antiproliferative activity of 2,6-Dibenzylamino-3,5-dicyanopyridines on human cancer cell lines 12.493
Synthesis and biological evaluation of novel acylhydrazone derivatives as potential antitumor agents 6.602
Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen 4.901
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifabutina, rifampicina e amikacina nei confronti di Mycobacterium avium 4.606
Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel 2.853
Dihydroquinazoline and Triazinedione Derivatives as Prok1 and Prok2 receptor antagonists in HEK-293 transfected cells 2.730
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 2.706
TRPV1 modulators: synthesis and in vitro evaluation of 1-heteroarylpiperidinecarboxamide and piperazinylurea derivatives 2.659
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 2.596
Interaction of the N-(3-Methylpyridin-2-yl)amide derivatives of flurbiprofen and ibuprofen with FAAH: Enantiomeric selectivity and binding mode 2.541
Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives 2.522
Critical role for prokineticin 2 in CNS autoimmunity 2.456
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity 2.367
Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide 2.353
Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor 2.353
Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization 2.248
Synthesis and evaluation of new pyrazole-based carboxamides as modulators of the TrPv1 channel 2.204
New bis(pyridyl)methane derivatives from 4-hydroxy-2-pyridones: synthesis and antitumoral activity 2.201
Antagonism of the prokineticin system prevents and reverses allodynia and inflammation in a mouse model of diabetes 2.121
Investigation of the mechanism of FAAH inhibition of profen amide derivatives 2.118
Simple synthesis of polyfunctional nitropyridines 2.085
A new and efficient synthesis of phthalazin-1(2H)-ones 2.063
Synthesis and SIRT1 modulation studies of amides and hydrazides of benzoic acid incorporating a (2-trifluoromethylpyridin-4-yl)amino moiety 2.049
Synthesis of triflouromethylated pyridinecarbonitriles 2.048
2-Acylhydrazino-5-arylpyrrole derivatives: Synthesis and antifungal activity evaluation 1.999
A novel inhibitor of fatty acid amide hydrolase, the enzyme responsible for the hydrolysis of the endocannabinoid anandamide 1.972
Interaction and reactivity of synthetic aminoisoflavones with metal-free and metalassociated amyloid-beta 1.896
A novel inhibitor of fatty acid amide hydrolase, the enzyme responsible for the hydrolysis of the endocannabinoid anandamide 1.844
An important role for prokineticin 2 in autoimmune CNS demyelination 1.811
Synthesis and antitumor evaluation of 6-thioxo-, 6-oxo- and 2,4-dioxopyrimidine derivatives 1.804
PPAR controls pregnancy outcome through activation of EG-VEGF: new insights into the mechanism of placental development 1.803
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties 1.787
null 1.768
Reaction of enaminonitriles with isocyanates. Synthesis of new 2-oxo- and 6-oxopyrimidines 1.755
null 1.650
Synergistic interaction in vitro between rifabutin and newly synthesized S-alkylisothiosemicarbazones derivatives against mycobacterium avium 1.456
DESIGN, SYNTHESIS, AND EVALUATION OF (ISO)NIPECOTAMIDE AND PIPERAZINYLUREA DERIVATIVES AS TRPV1 MODULATORS 1.374
Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins 1.349
Synergistic interactions in vitro between Rifabutin and newly synthesized s-alkylthiosemicarbazone derivatives against M. avium 1.270
New trifluoromethylated pyridines from functionalized N-1-acylacetamidrazones 1.245
null 1.242
Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context 1.227
Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain 1.167
Synthesis of ibuprofen heterocyclic amides and investigation of their analgesic and toxicological properties 1.094
Synthesis and Carbonic Anhydrase Inhibitory Activity of New 2-Aminochromenone Derivatives 907
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore 840
Synthesis and biological activity of prokineticin receptors antagonists and their development as a biomarker for imaging inflammatory pain 829
null 825
Reactivity of N1-Acylacetamidrazones towards Diethyl Acetylenedicarboxylate: Cyclization to Ethyl Pyrroleacetates and 1-Acylaminopyridones 818
Design, Synthesis and Evaluation of new 2-(Arylidenehydrazino)pyrrole Derivatives as Potential Antitumor Agents 806
Synthesis and in vitro antitumoral activity of new hydrazinopyrimidine-5-carbonitrile derivatives 740
null 731
Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives 724
Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors 709
In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium 705
Synthesis and evaluation of anticancer activity of 2-arylamino-6-trifluoromethyl-3-(hydrazonocarbonyl)pyridines 702
null 670
Synthesis of new N-(2-(trifluoromethyl)pyridin-4-yl)anthranilic acid derivatives and their evaluation as anticancer agents 655
DESIGN, SYNTHESIS, BIOLOGICAL ACTIVITY AND SAR OF DUAL FAAH – COX INHIBITORS 625
null 613
Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues 613
Synthesis and evaluation of antitumoral activity of ester and amide derivatives of 2-arylamino-6- trifluoromethyl-3-pyridinecarboxylic acids 605
Synthesis and structural studies of 3-acylamino-4-amino-2,3-dihydro-2-iminothiazole-5-carboxylates and 4-acylhydrazino-2-aminothiazole-5-carboxylates 558
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore 555
Synthesis and antimicrobial activity of some pyrrole derivatives 511
Synthesis and antimicrobial activity of some 1-arylideneamino-2-mercaptoimidazole derivatives 494
null 466
null 457
Synthesis and antimicrobial activity of some pyrrole derivatives. III. 2-(4-arylpiperazino)-3-ethoxycarbonyl-5-aryl-pyrrole derivatives. 445
Synthesis and antimicrobial activity of some pyrrole derivatives. IV. 2-arylidenhydrazino-3-ethoxycarbonyl (or cyano) pyrrole derivatives. 436
Synthesis and in vitro antitumoral activity of new N-phenyl-3-pyrrolecarbothioamides 433
null 424
Design, synthesis and pharmacological investigation on new FAAH inhibitors 421
Attività antimicrobica di derivati pirrolici 417
null 416
null 414
DESIGN, SYNTHESIS, BIOLOGICAL ACTIVITY AND SAR OF NEW FAAH INHIBITORS 413
PROGETTAZIONE, SINTESI, STUDI SAR E VALUTAZIONE BIOLOGICA DI NUOVIINIBITORI DELL’ENZIMA FAAH 404
Synthesis and structure of heterocyclic compounds, 1-amino-2,4-disubstituted imidazoles. 387
Synthesis of 1-acyl-5-pyrazolones and pyrrolidino [2,3-c]pyrazol-3-ones 384
Design, Synthesis, Biological Activity and SAR of New FAAH Inhibitors 381
Synergistic activity between rifamycins and a new class of isothiosemicarbazones against Mycobacterium avium 378
null 378
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifampicina e rifabutina nei confronti di Mycobacterium avium 376
Synthesis and antifungal activities of N-arylideneaminoimidazole derivatives. 375
Synthesis of 6-amino and 6-ethoxy-2(1H)-pyridone derivatives. 373
DERIVATI DIARILETEROCICLICI COME POTENZIALI AGENTI ANTITUMORALI 367
Synthesis and in vitro antitumoral activity of new 3,5-dicyanopyridine derivatives 367
null 361
Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis 351
Synthesis and antimycobacterial activity of new S-alkylisotiosemicarbazone derivatives 351
null 350
Attività Antimicobatterica di Nuovi S-alchilisotiosemicarbazoni e Potenziamento dell’Attività di Rifampicina e Rifabutina nei Confronti di M. Avium 345
null 341
null 341
Synthesis and Antitubercular activity of N1-Isonicotinoylamidrazones Derivatives 337
Synergistic Activity between Rifamycins and a New Class of Isothiosemicarbazones against Mycobacterium avium 336
null 332
Concentrazioni sub-inibenti di isonicotinoilidrazoni potenziano l'attività di rifampicina e etambutolo nei confronti di Mycobacterium tuberculosis 330
null 327
Totale 135.637
Categoria #
all - tutte 199.197
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 199.197


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.400 0 0 0 0 0 0 0 0 0 1.106 1.192 1.102
2021/20224.171 381 345 336 236 225 315 313 293 281 470 353 623
2022/20237.334 730 726 657 519 535 908 490 1.070 467 345 575 312
2023/20249.379 422 365 449 713 975 1.628 1.563 546 446 645 743 884
2024/202555.285 20.762 13.225 13.053 2.052 1.635 1.129 1.205 155 327 1.260 194 288
2025/202611.115 299 410 844 747 289 352 950 577 5.939 708 0 0
Totale 155.565